BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2015 4:09:00 PM | Browse: 1377 | Download: 2238
 |
Received |
|
2014-03-19 09:53 |
 |
Peer-Review Started |
|
2014-03-19 13:07 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-05-05 10:36 |
 |
Revised |
|
2014-05-16 10:03 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-07-16 12:55 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-07-16 13:06 |
 |
Articles in Press |
|
2014-07-16 17:56 |
 |
Edit the Manuscript by Language Editor |
|
2014-07-27 20:36 |
 |
Typeset the Manuscript |
|
2014-12-27 20:28 |
 |
Publish the Manuscript Online |
|
2015-01-18 16:09 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Autobiography |
| Article Title |
E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Yuan Wei, Lin-Hai Yan, Xiao-Tong Wang, Lei Li, Wen-Long Cao, Xiao-Shi Zhang, Ze-Xu Zhan, Han Yu, Yu-Bo Xie and Qiang Xiao |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
30860273 |
| National Natural Science Foundation of China |
81060201 |
| Natural Science Foundation of Guangxi |
2011GXNSFA018273 |
| Natural Science Foundation of Guangxi |
2013GXNSFAA019163 |
| Key Health Science Project of Guangxi |
Key1298003-2-6 |
|
| Corresponding Author |
Qiang Xiao, Professor, Department of Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. xiaoqiang20050@aliyun.com |
| Key Words |
E2F-1; Gastric cancer; Lentiviral vector; Mouse model |
| Core Tip |
Transcription factor E2F-1 is the prototypical E2F and is often implicated in DNA synthesis and repair, cell proliferation, and apoptosis. Our preliminary study revealed that high expression of E2F-1 significantly suppressed gastric cancer (GC) cell line progression in vitro. However, the role of E2F-1 overexpression in GC in vivo remains unknown. Our results showed that overexpression of E2F-1 significantly inhibited tumor growth and promoted tumor cell apoptosis in vivo. Survivin, Bcl-2, cyclin D1, S-phase kinase-associated protein 2 and c-Myc were upregulated, and Bax was downregulated by E2F-1. E2F-1 inhibits growth of GC cells via regulating multiple signaling pathways. |
| Publish Date |
2015-01-18 16:09 |
| Citation |
Wei WY, Yan LH, Wang XT, Li L, Cao WL, Zhang XS, Zhan ZX, Yu H, Xie YB, Xiao Q. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo. World J Gastroenterol 2015; 21(2): 491-501 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i2/491.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i2.491 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.